Comparing Two Radiotherapy Schedules for Lung Cancer
Author Information
Author(s): Ewa Senkus-Konefka, Rafal Dziadziuszko, Ewa Bednaruk-Młyński, Agnieszka Pliszka, Jacek Kubrak, Agnieszka Lewandowska, Krzysztof Małachowski, Marek Wierzchowski, Monika Matecka-Nowak, Jan Jassem
Primary Institution: Medical University of Gdańsk
Hypothesis
Is a 2-fraction radiotherapy schedule as effective as a 5-fraction schedule for palliative treatment of non-small-cell lung cancer?
Conclusion
The study found that both radiotherapy schedules provided similar symptom relief, but the 2-fraction schedule resulted in significantly longer overall survival.
Supporting Evidence
- 98 patients received assigned treatment, with good tolerance and no significant differences in symptom relief between groups.
- Overall survival was significantly longer in the 16 Gy/2 fr group compared to the 20 Gy/5 fr group.
- Both treatment schedules provided effective palliation of symptoms related to lung cancer.
Takeaway
Doctors tested two ways to give radiation to lung cancer patients. They found that giving it in two big doses worked just as well and helped patients live longer than giving it in five smaller doses.
Methodology
Patients were randomly assigned to receive either 20 Gy in 5 fractions or 16 Gy in 2 fractions, and their symptoms and overall survival were assessed.
Potential Biases
Potential imbalance in patient characteristics between treatment groups due to small sample size.
Limitations
The study was closed prematurely due to decreasing patient accrual, which may affect the reliability of the results.
Participant Demographics
100 patients, 90 men and 10 women, aged 47–81 years (mean 66), with performance status 1–4 (median 2).
Statistical Information
P-Value
0.016
Confidence Interval
95% CI: 42–72% for 6-month survival in 16 Gy/2 fr group
Statistical Significance
p=0.016
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website